SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-010986
Filing Date
2012-11-05
Accepted
2012-11-05 16:11:00
Documents
13
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pdl_10q-093012.htm 10-Q 1130352
2 EXHIBIT 12.1 ex12-1.htm EX-12.1 33684
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 11564
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 11730
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 6251
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 6513
13 image.jpg GRAPHIC 7005
  Complete submission text file 0001437749-12-010986.txt   9417805

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE pdli-20120930.xml EX-101.INS 1924797
8 XBRL TAXONOMY EXTENSION SCHEMA pdli-20120930.xsd EX-101.SCH 64524
9 XBRL TAXONOMY EXTENSION CALCULATION pdli-20120930_cal.xml EX-101.CAL 47184
10 XBRL TAXONOMY EXTENSION DEFINITION pdli-20120930_def.xml EX-101.DEF 353597
11 XBRL TAXONOMY EXTENSION LABELS pdli-20120930_lab.xml EX-101.LAB 447571
12 XBRL TAXONOMY EXTENSION PRESENTATION pdli-20120930_pre.xml EX-101.PRE 357719
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 121180177
SIC: 2836 Biological Products, (No Diagnostic Substances)